Findings: WEIGHT LOSS IN ADOLESCENTS The STEP TEENS study detailed below evaluated the effects of Wegovy on weight loss in obese adolescents aged 12 - 17 years RCT STEP TEENS Study - Wegovy vs Placebo for Weight Loss in Obese Adolescents, NEJM (2022) [PubMed abstract] The STEP TEENS study enrolled 201 obese adolescents aged 12 - 17 years Main inclusion criteria Age 12 to 10% Baseline characteristics Average age 15.4 years Female sex - 62% Average weight - 238 lbs (108 kg) Average BMI - 37 Randomized treatment groups Group 1 (134 patients): Wegovy 2.4 mg once weekly Group 2 (67 patients): Placebo Before treatment, all patients underwent a 12-week run-in phase where they received lifestyle interventions Wegovy was started at 0.25 mg once weekly and titrated to 2.4 mg over 16 weeks Percentage change in BMI from baseline to week 68 Primary outcome: Results Among adolescents with obesity, once-weekly treatment with a 2.4-mg dose of semaglutide plus lifestyle intervention resulted in a greater reduction in BMI than lifestyle intervention alone Findings: Summary Wegovy caused impressive weight loss in the STEP TEENS study, and its effects were greater than other drugs approved for adolescent obesity (see Qsymia and Saxenda)
71 In the context of MASLD, iHSP72 exerts hepatoprotective effects by attenuating oxidative stress, reducing lipid accumulation, and limiting inflammatory responses
The cohort skews toward English-language US-shipping research-grade vendors
Cmo tomar L-Carnitina Tartrate x60 de HTN
Commonly stacked with caffeine, CoQ10, or ALA for synergy
Glutathione Nasal Spray is a simple, proactive solution that helps: Support your upper respiratory tract Protect cells from environmental oxidative stress Support mental clarity, immune function, and increased energy Boost feelings of overall wellbeing Feel immediate benefits with our daily Nasal Spray formula, compounded in our speciality pharmacy to support the bodys natural antioxidant systems and help maintain cellular balance
